A citation-based method for searching scientific literature

Felice Nappi, Antonietta La Verde, Giovanni Carfora, Carlo Garofalo, Michele Provenzano, Ferdinando Carlo Sasso, Luca De Nicola. Medicina (Kaunas) 2019
Times Cited: 7







List of co-cited articles
53 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
57

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
57


Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
11
57

Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter 2 Inhibitor Use in Two Patients Undergoing Pancreatectomy.
Devon J Pace, Katerina Dukleska, Samantha Phillips, Vanessa Gleason, Charles J Yeo. J Pancreat Cancer 2018
11
57

Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy.
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
7
57


SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
99
42

Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
Erasmia Sampani, Pantelis Sarafidis, Chrysostomos Dimitriadis, Efstratios Kasimatis, Dimitra Daikidou, Konstantinos Bantis, Alexios Papanikolaou, Aikaterini Papagianni. BMC Nephrol 2020
7
42




Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
Masafumi Fukuda, Masakazu Nabeta, Takanori Muta, Kei Fukami, Osamu Takasu. Int J Emerg Med 2020
6
50


Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report.
Sang Mok Yeo, Hayeon Park, Jin Hyuk Paek, Woo Yeong Park, Seungyeup Han, Sung Bae Park, Kyubok Jin. Medicine (Baltimore) 2019
7
42


Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
28


SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report.
Katherine M Wang, Robert T Isom. Kidney Med 2020
14
28

Euglycaemic diabetic ketoacidosis.
J F Munro, I W Campbell, A C McCuish, L J Duncan. Br Med J 1973
161
28

Euglycemic Diabetic Ketoacidosis Precipitated by a Keto Diet: Importance of Dietary History in Diagnosis.
Safia Shaikh, Mohamed Mg Mohamed, Abdul Mujeeb, Faizan Shaikh, Benjamin Harris. Cureus 2020
5
40

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
179
28

Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma.
Prashanth Rawla, Anantha R Vellipuram, Sathyajit S Bandaru, Jeffrey Pradeep Raj. Endocrinol Diabetes Metab Case Rep 2017
28
28

Sodium-glucose cotransport.
Søren Brandt Poulsen, Robert A Fenton, Timo Rieg. Curr Opin Nephrol Hypertens 2015
68
28

Euglycemic Diabetic Ketoacidosis Due to Gastroparesis, A Local Experience.
Ronillo Legaspi, Philipp Narciso. J Ark Med Soc 2015
9
28

Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature.
Pablo Lucero, Sebastián Chapela. Case Rep Crit Care 2018
18
28

SUCCESSFUL REIMPLEMENTATION OF A VERY LOW CARBOHYDRATE KETOGENIC DIET AFTER SGLT2 INHIBITOR ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS.
Ethan I Fieger, Kristen M Fadel, Amir H Modarres, Edmond P Wickham, Susan E Wolver. AACE Clin Case Rep 2020
2
100

Euglycemic Diabetic Ketoacidosis: A Review.
Anar Modi, Abhinav Agrawal, Farah Morgan. Curr Diabetes Rev 2017
77
28

Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit.
Fernand Bteich, Ghassan Daher, Aniruddh Kapoor, Edward Charbek, Ghassan Kamel. Cureus 2019
4
50

The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin.
Nellowe Candelario, Jedrzej Wykretowicz. Oxf Med Case Reports 2016
22
28

Sodium-Glucose Linked Transporter Inhibitors as a Cause of Euglycemic Diabetic Ketoacidosis on a Background of Starvation.
Abubakar Tauseef, Muhammad Sohaib Asghar, Maryam Zafar, Noman Lateef, Joseph Thirumalareddy. Cureus 2020
4
50

Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
Yuita Fukuyama, Kenji Numata, Kaede Yoshino, Takushi Santanda, Hiraku Funakoshi. Acute Med Surg 2020
9
28



A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed.
Samantha Steinmetz-Wood, Matthew Gilbert, Katherine Menson. Case Rep Endocrinol 2020
7
28

Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats.
Rachel J Perry, Aviva Rabin-Court, Joongyu D Song, Rebecca L Cardone, Yongliang Wang, Richard G Kibbey, Gerald I Shulman. Nat Commun 2019
39
28

Prolonged euglycemic diabetic ketoacidosis triggered by a single dose of sodium-glucose cotransporter 2 inhibitor.
Maki Miwa, Mikio Nakajima, Richard H Kaszynski, Hideaki Goto. BMJ Case Rep 2020
3
66



Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis.
Iqra Iqbal, Mohsin Hamid, Muhammad Atique Alam Khan, Aleesha Kainat, Shafaq Tariq. Cureus 2019
10
28

Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors.
An-Yi Wang, Sen-Kuang Hou, Shan-Jen Li, Wei-Fong Kao. Am J Emerg Med 2017
5
40

Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.
Jenny E Blau, Sri Harsha Tella, Simeon I Taylor, Kristina I Rother. Diabetes Metab Res Rev 2017
89
28



Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
28

Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors.
J Y Jeon, S-K Kim, K-S Kim, S O Song, J-S Yun, B-Y Kim, C-H Kim, S O Park, S Hong, D H Seo,[...]. Diabetes Metab 2019
11
28

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
28

Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
Yu-Mou Chou, Chen-June Seak, Zhong Ning Leonard Goh, Joanna Chen-Yeen Seak, Chen-Ken Seak, Chih-Chuan Lin. Medicine (Baltimore) 2018
17
28


SGLT2 Inhibitors May Predispose to Ketoacidosis.
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J Clin Endocrinol Metab 2015
288
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.